Systematic Reviews
Copyright ©The Author(s) 2025.
World J Hepatol. Feb 27, 2025; 17(2): 100033
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.100033
Table 8 Vibration-controlled transient elastography diagnostic efficacy (area under the receiver operating characteristic curves for fibrosis detection)
Ref.
Number of patients
Disease/diagnose
Diagnostic method
Fibrosis stage
AUROC (CI)
Assessment
Cassinotto et al[23]577NAFLDVCTEF ≥ 20.80 (0.76-0.84)Acceptable
F ≥ 30.82 (0.78-0.86)Good
F40.85 (0.80-0.90)Good
Gatos et al[27]152CLDVCTEF ≥ F10.9900Excellent
F ≥ F20.9767Excellent
F ≥ F30.9651Excellent
F = F40.9645Excellent
Imajo et al[66]231NAFLDVCTEF40.87 (0.80-0.91)Good
Nogami et al[36]163NAFLDVCTE≥ F20.855 (0.83-0.94)Good
≥ F30.925 (0.90-0.95)Excellent
F40.88 (0.87-0.89)Good
Sharpton et al[43]114CLDVCTEF2-F40.86 (0.80-0.93)Good
F3-F40.91 (0.82-0.99)Excellent
F40.96 (0.91-1.00)Excellent
Atzori et al[22]160CLDVCTEF0/10.810 (0.746-0.884)Good
F3/40.841 (0.771-0.910)Good
F40.939 (0.896-0.982)Excellent
Damjanovska et al[24]93NAFLDVCTEF40.77 (0.66-0.88)Acceptable
Mikolasevic et al[35]179NAFLDVCTE≥ F30.98Excellent
F40.98Excellent
Roccarina et al[40]671NAFLDVCTEF > 10.792 (0.60-0.91)Acceptable
F > 20.849 (0.78-0.91)Good
F > 30.851 (0.79-0.91)Good
F = 40.911 (0.83-0.96)Excellent
Zougmoréet al[55]476CLDVCTE≥ F20.86 (0.81-0.91)Good
≥ F30.89 (0.85-0.93)Good
≥ F40.90 (0.86-0.94)Good